NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Government Regulation Remove constraint Subjects: Government Regulation

Search Results

411. States reported multiple challenges with using telehealth to provide behavioral health services to Medicaid enrollees

413. States’ backlogs of standard surveys of nursing homes grew substantially during the COVID-19 pandemic

414. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

415. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

416. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

417. Concerns persist about opioid overdoses and Medicare beneficiaries’ access to treatment and overdose-reversal drugs

418. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

419. Drug safety: FDA should take additional steps to improve its foreign inspection program : report to congressional requesters

420. Some Medicare Advantage companies leveraged chart reviews and health risk assessments to disproportionately drive payments